tiprankstipranks
Cryolife (CRY)
NYSE:CRY
US Market

Cryolife (CRY) Stock News & Sentiment

0 Followers
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cryolife (CRY – Research Report) and Genocea Biosciences (GNCA – Research Report) with bullish sentiments. Cryolife (CRY) In a report released today, Michael Matson from Needham reiterated a Buy rating on Cryolife, with a price target of $38.00. The company’s shares closed last Thursday at $27.39. According to TipRanks.com, Matson is a 5-star analyst with an average return of 17.4% and a 69.4% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Zimmer Biomet Holdings, and Cardiovascular Systems. Currently, the analyst consensus on Cryolife is a Moderate Buy with an average price target of $34.67. See today’s analyst top recommended stocks >> Genocea Biosciences (GNCA) H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Genocea Biosciences today and set a price target of $9.00. The company’s shares closed last Thursday at $2.02, close to its 52-week low of $1.80. According to TipRanks.com, Pantginis is a 5-star analyst with an average return of 28.2% and a 47.2% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as Applied Genetic Technologies, Lineage Cell Therapeutics, and Catabasis Pharmaceuticals. Currently, the analyst consensus on Genocea Biosciences is a Strong Buy with an average price target of $7.00, a 241.5% upside from current levels. In a report issued on July 14, Robert W. Baird also maintained a Buy rating on the stock with a $8.00 price target. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Read More on CRY: ECN Capital Continues to Captivate Investors bluebird bio: Mizuho Analysts Stick to “Buy” Despite Looming Vector Shortages Facebook vs.Twitter: Which Social Media Stock Is A More Compelling Buy? Enphase Beating Odds; Needham Reiterates “Buy” Suncor Energy Swings to Profit in Q2 ...Read more

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CRY’s Media Buzz Sentiment?
Currently, no data Available
What is CRY’s weekly average amount of articles?
Currently, no data Available
What is CRY’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
ZGNXZogenix
GMDAGamida Cell
KURAKura Oncology
ISRGIntuitive Surgical
VALNValneva
Showing the stocks with the most bullish news sentiment over the past week
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis